- Home
- LENZ vs PSBD Comparison
LENZ vs PSBD Comparison
Compare LENZ & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- PSBD
- Stock Information
- Founded
- LENZ 2019
- PSBD 2009
- Country
- LENZ United States
- PSBD United States
- Employees
- LENZ N/A
- PSBD N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- PSBD
- Sector
- LENZ Health Care
- PSBD
- Exchange
- LENZ Nasdaq
- PSBD Nasdaq
- Market Cap
- LENZ 614.9M
- PSBD 519.7M
- IPO Year
- LENZ 2021
- PSBD 2024
- Fundamental
- Price
- LENZ $23.82
- PSBD $15.75
- Analyst Decision
- LENZ Strong Buy
- PSBD Buy
- Analyst Count
- LENZ 6
- PSBD 7
- Target Price
- LENZ $35.40
- PSBD $16.93
- AVG Volume (30 Days)
- LENZ 197.6K
- PSBD 17.7K
- Earning Date
- LENZ 11-06-2024
- PSBD 02-08-2025
- Dividend Yield
- LENZ 30.67%
- PSBD 12.02%
- EPS Growth
- LENZ N/A
- PSBD N/A
- EPS
- LENZ N/A
- PSBD N/A
- Revenue
- LENZ N/A
- PSBD N/A
- Revenue This Year
- LENZ N/A
- PSBD N/A
- Revenue Next Year
- LENZ N/A
- PSBD N/A
- P/E Ratio
- LENZ N/A
- PSBD N/A
- Revenue Growth
- LENZ N/A
- PSBD N/A
- 52 Week Low
- LENZ $2.57
- PSBD $15.12
- 52 Week High
- LENZ $38.93
- PSBD $17.12
- Technical
- Relative Strength Index (RSI)
- LENZ 35.08
- PSBD 52.81
- Support Level
- LENZ $21.34
- PSBD $15.17
- Resistance Level
- LENZ $23.84
- PSBD $16.07
- Average True Range (ATR)
- LENZ 1.58
- PSBD 0.42
- MACD
- LENZ -0.39
- PSBD 0.06
- Stochastic Oscillator
- LENZ 25.78
- PSBD 61.76
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.